(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | |||||
Gross profit | |||||
Operating expense | 1,439.55%47.68K | -5.41%25.95K | 67.11K | 3.1K | 27.43K |
Selling and administrative expenses | 1,101.49%37.21K | -5.41%25.95K | --67.11K | --3.1K | --27.43K |
-General and administrative expense | 1,101.49%37.21K | -5.41%25.95K | --67.11K | --3.1K | --27.43K |
Other operating expenses | --10.47K | ---- | ---- | ---- | ---- |
Operating profit | -1,439.55%-47.68K | 5.41%-25.95K | -67.11K | -3.1K | -27.43K |
Net non-operating interest income (expenses) | |||||
Other net income (expenses) | |||||
Income before tax | -1,439.55%-47.68K | 5.41%-25.95K | -67.11K | -3.1K | -27.43K |
Income tax | |||||
Earnings from equity interest net of tax | |||||
Net income | -1,439.55%-47.68K | 5.41%-25.95K | -67.11K | -3.1K | -27.43K |
Net income continuous operations | -1,439.55%-47.68K | 5.41%-25.95K | ---67.11K | ---3.1K | ---27.43K |
Noncontrolling interests | |||||
Net income attributable to the company | -1,439.55%-47.68K | 5.41%-25.95K | -67.11K | -3.1K | -27.43K |
Preferred stock dividends | |||||
Other under preferred stock dividend | |||||
Net income attributable to common stockholders | -1,439.55%-47.68K | 5.41%-25.95K | -67.11K | -3.1K | -27.43K |
Diluted earnings per share | -1,414.29%-0.0004 | 5.33%-0.0002 | -0.0006 | -0 | -0.0002 |
Basic earnings per share | -1,414.29%-0.0004 | 5.33%-0.0002 | -0.0006 | -0 | -0.0002 |
Dividend per share | |||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data